25-Hydroxyvitamin D Concentrations and Clostridium difficile Infection: A Meta-Analysis
Date
2017Author
Furuya-Kanamori, L.Wangdi, K.
Yakob, L.
McKenzie, S.J.
Doi, S.A.R.
Clark, J.
Paterson, D.L.
Riley, T.V.
Clements, A.C.A.
...show more authors ...show less authors
Metadata
Show full item recordAbstract
Background: Well-known risk factors for Clostridium difficile infection (CDI) are exposure to antibiotics and gastric acid suppressants. Recent studies have provided some evidence of an association between hypovitaminosis D and the risk of CDI. Therefore, this meta-analysis aimed to pool all the existing evidence to investigate the association between 25-hydroxyvitamin D (25[OH]D) and CDI. Methods: A systematic search was conducted in 3 databases (PubMed, Embase, and Web of Sciences) for epidemiological studies that examined the association between mean 25(OH)D concentrations and CDI as well as between 25(OH)D status and CDI severity or recurrence. 25(OH)D status was defined as "lower" or "higher" at a threshold concentration of <20 or - 20 ng/mL, respectively. Pooled effect sizes were computed using the inverse variance heterogeneity model of meta-analysis. Results: Eight publications (n = 4479 patients) were included in the meta-analysis. The mean concentration of 25(OH)D in patients with CDI was 3.54 ng/mL (95% confidence interval [CI], 0.39-6.89 ng/mL) lower than in patients without CDI. Patients with lower 25(OH)D status had a higher odds (odds ratio [OR], 1.61; 95% CI, 1.02-2.53) of developing severe CDI compared with those with a higher 25(OH)D status. No significant association was found between 25(OH)D status and CDI recurrence. Conclusion: The results of this meta-analysis suggest that lower mean concentrations of 25(OH)D were associated with CDI. A lower 25(OH)D status increased the odds of severe CDI but not of CDI recurrence. ? 2015 The American Society for Parenteral and Enteral Nutrition.
Collections
- Medicine Research [1379 items ]
Related items
Showing items related by title, author, creator and subject.
-
Reply to "Double-counting of effect sizes and inappropriate exclusion of studies in "The influence of vitamin D supplementation on IGF-1 levels in humans: A systematic review and meta_analysis"
Kord-Varkaneh, Hamed; Rinaldi, Giulia; Hekmatdoost, Azita; Fatahi, Somaye; Tan, Shing Cheng; Shadnoush, Mahdi; Khni, Vahid; Mousavi, Seyed Mohammad; Zarezadeh, Meysam; Salamat, Shekoufeh; Bawadi, Hiba; Rahmani, Jamal... more authors ... less authors ( Elsevier , 2021 , Other)Dear Editor, We appreciate the comments provided to us in the letter from Amiri et al. We would like to offer some clarifications in response to the comments. Firstly, the authors claimed that we included the control ... -
Prospective cohort study of vitamin D deficiency in pregnancy: Prevalence and limited effectiveness of 1000 IU vitamin D supplementation
Abdelmageed, Rasha Mohammed; Hussein, Suha Majeed Mohammed; Anamangadan, Shamil Mohamed; Abdullah, Rola Walid Mahmoud; Rauf, Lubna; AlFehaidi, Al Anoud Saleh; Hamed, Ehab... more authors ... less authors ( SAGE , 2024 , Article)Background: Vitamin D deficiency is highly prevalent worldwide among pregnant women. Although vitamin D supplementation is effective in improving vitamin D status, the safety and optimal dosing of vitamin D supplementation ... -
Impact of GGCX, STX1B and FPGS Polymorphisms on Warfarin Dose Requirements in European-Americans and Egyptians
Hamadeh, IS; Shahin, MH; Lima, SM; Oliveira, F; Wilson, L; Khalifa, SI; Langaee, TY; Cooper-DeHoff, RM; Cavallari, LH; Johnson, JA... more authors ... less authors ( Blackwell Publishing Ltd , 2016 , Article)Genotype-based algorithms that include VKORC1 and CYP2C9 genotypes are less predictive of warfarin dose variability in Africans as opposed to Europeans. Polymorphisms in GGCX, FPGS, or STX1B are associated with warfarin ...